Viyash Scientific · NSE: VIYASH · BSE: 512529
Q4 FY23 results · Jan–Mar 2023
Viyash Scientific reported revenue from operations of ₹366.67 crore (down 4.4% from Q4 FY22) and net loss of ₹92.44 crore for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 366.67 | 383.71 | −4.4% | 375.31 | −2.3% |
| Other income | 1.74 | 3.77 | −53.9% | 2.86 | −39.3% |
| Total income | 368.40 | 387.48 | −4.9% | 378.18 | −2.6% |
| Profit before tax | (88.80) | 18.61 | Turned loss | (10.20) | Loss widened |
| Net profit for the period | (92.44) | 10.04 | Turned loss | (9.78) | Loss widened |
| Attributable to shareholders of the company | (93.57) | 8.96 | Turned loss | (8.87) | Loss widened |
| EPS, basic (₹) | (3.77) | 0.36 | Turned loss | (0.36) | Loss widened |
| Net margin (%) | -25.2 | 2.6 | -2.6 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 46.59 | 63.67 | −26.8% | 57.00 | −18.3% |
| Other income | 8.01 | 5.77 | +38.8% | 7.62 | +5.1% |
| Total income | 54.61 | 69.44 | −21.4% | 64.62 | −15.5% |
| Profit before tax | (1.23) | 8.04 | Turned loss | (3.99) | Loss narrowed |
| Net profit for the period | (1.65) | 6.65 | Turned loss | (1.23) | Loss widened |
| EPS, basic (₹) | (0.07) | 0.27 | Turned loss | (0.05) | Loss widened |
| Net margin (%) | -3.5 | 10.4 | -2.1 |
Consolidated
- Filed with BSE
- 24 May 2023, 18:43 IST
- Board meeting
- 23 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 May 2023, 18:43 IST
- Board meeting
- 23 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE